Array
(
)
1
> Function Modulators>Maytansinoid DM4

Function Modulators

Maytansinoid DM4 View larger

Maytansinoid DM4

AOB31044

CAS: 796073-69-3

 

Chemical Name: DM4; (1(4)S,1(6)S,3(2)S,3(3)S,2R,4S,10E,12E,14R)-8(6)-chloro-1(4)-hydroxy-8(5),14-dimethoxy-3(3),2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-(4-mercapto-4-methylpentanoyl)-N-methyl-L-alaninate

More details

1000 Items

Molarity Calculation Cart®

HOW TO ORDER

$21.00

$21.00 per mg

Quantity Discount Table - Order More To Get More Price Discount

QuantitymgUnit Price ($/mg or $/Unit)Final Price
15 $17.85 Total: $89.25
110 $15.12 Total: $151.20
125 $12.81 Total: $320.25
150 $10.92 Total: $546.00
1100 $9.45 Total: $945.00

Data sheet

Molecular FormulaC38H54ClN3O10S
Molecular Weight780.37
CAS Numbers796073-69-3
Storage Condition0°C (short term), -20°C (long term), desiccated
SolubilityDMSO
Purity98% by HPLC
SynonymMaytansinoid DM4; DM4, Ravtansine, Soravtansine
IUPAC/Chemical Name (14S,16S,32S,33S,2R,4S,10E,12E,14R)-86-chloro-14-hydroxy-85,14-dimethoxy-33,2,7,10-tetramethyl-12,6-dioxo-7-aza-1(6,4)-oxazinana-3(2,3)-oxirana-8(1,3)-benzenacyclotetradecaphane-10,12-dien-4-yl N-(4-mercapto-4-methylpentanoyl)-N-methyl-L-alaninate
InChl Key JFCFGYGEYRIEBE-YVLHJLIDSA-N
InChl CodeInChI=1S/C38H54ClN3O10S/c1-21-12-11-13-28(49-10)38(47)20-27(50-35(46)40-38)22(2)33-37(6,52-33)29(51-34(45)23(3)41(7)30(43)14-15-36(4,5)53)19-31(44)42(8)25-17-24(16-21)18-26(48-9)32(25)39/h11-13,17-18,22-23,27-29,33,47,53H,14-16,19-20H2,1-10H3,(H,40,46)/b13-11+,21-12+/t22-,23+,27+,28-,29+,33+,37+,38+/m1/s1
SMILES CodeC/C(CC1=CC(OC)=C(Cl)C(N(C(C[C@]([C@]2(C)O[C@H]2[C@@H]3C)([H])OC([C@@H](N(C(CCC(C)(C)S)=O)C)C)=O)=O)C)=C1)=CC=C[C@@H](OC)[C@](NC4=O)(C[C@]3([H])O4)O
References1) Schönfeld K, Zuber C, Pinkas J, Häder T, Bernöster K, Uherek C. Indatuximab ravtansine (BT062) combination treatment in multiple myeloma: pre-clinical studies. J Hematol Oncol. 2017 Jan 11;10(1):13. doi: 10.1186/s13045-016-0380-0. PubMed PMID: 28077160; PubMed Central PMCID: PMC5225632.

2) Reichert JM. Antibodies to watch in 2017. MAbs. 2017 Feb/Mar;9(2):167-181. doi: 10.1080/19420862.2016.1269580. Epub 2016 Dec 14. PubMed PMID: 27960628; PubMed Central PMCID: PMC5297518.

More info

Potent and selective cytotoxic agent, being used to conjugate with antibody drugs, such as Anetumab ravtansine (BAY 94-9343) and Indatuximab ravtansine (BT062)